Homozygous GRN mutations: new phenotypes and new insights into pathological and molecular mechanisms
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Homozygous mutations in the progranulin gene (GRN) are associated with neuronal ceroid lipofuscinosis 11 (CLN11), a rare lysosomal-storage disorder characterized by cerebellar ataxia, seizures, retinitis pigmentosa, and cognitive disorders, usually beginning between 13 and 25 years of age. This is a rare condition, previously reported in only four families. In contrast, heterozygous GRN mutations are a major cause of frontotemporal dementia associated with neuronal cytoplasmic TDP-43 inclusions. We identified homozygous GRN mutations in six new patients. The phenotypic spectrum is much broader than previously reported, with two remarkably distinct presentations, depending on the age of onset. A childhood/juvenile form is characterized by classical CLN11 symptoms at an early age at onset. Unexpectedly, other homozygous patients presented a distinct delayed phenotype of frontotemporal dementia and parkinsonism after 50 years; none had epilepsy or cerebellar ataxia. Another major finding of this study is that all GRN mutations may not have the same impact on progranulin protein synthesis. A hypomorphic effect of some mutations is supported by the presence of residual levels of plasma progranulin and low levels of normal transcript detected in one case with a homozygous splice-site mutation and late onset frontotemporal dementia. This is a new critical finding that must be considered in therapeutic trials based on replacement strategies. The first neuropathological study in a homozygous carrier provides new insights into the pathological mechanisms of the disease. Hallmarks of neuronal ceroid lipofuscinosis were present. The absence of TDP-43 cytoplasmic inclusions markedly differs from observations of heterozygous mutations, suggesting a pathological shift between lysosomal and TDP-43 pathologies depending on the mono or bi-allelic status. An intriguing observation was the loss of normal TDP-43 staining in the nucleus of some neurons, which could be the first stage of the TDP-43 pathological process preceding the formation of typical cytoplasmic inclusions. Finally, this study has important implications for genetic counselling and molecular diagnosis. Semi-dominant inheritance of GRN mutations implies that specific genetic counselling should be delivered to children and parents of CLN11 patients, as they are heterozygous carriers with a high risk of developing dementia. More broadly, this study illustrates the fact that genetic variants can lead to different phenotypes according to their mono- or bi-allelic state, which is a challenge for genetic diagnosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Low CSF and blood progranulin levels have been found in GRN mutation carriers with an almost 100% diagnostic accuracy.”
From New developments of biofluid‐based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia (2022) · cites this paper as [105]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
Rascovsky, K., Hodges, J. R., Knopman, D., Mendez, M. F., Kramer, J. H., Neuhaus, J., van Swieten, J. C., Seelaar, H., Dopper, E. G. P., Onyike, C. U., et al. (2011) · Brain · doi:10.1093/brain/awr179 · Cited by 5,221 · cited 6×
“Proband from family FTD-1042, and patients 1 and 2 from family FTDP-N12/1611, have developed behavioural and cognitive symptoms responding to the international clinical criteria of ‘probable’ bvFTD (Rascovsky et al., 2011).”
BackgroundMethodResultInfluentialClassification of primary progressive aphasia and its variants
Gorno-Tempini, M. L., Hillis, A. E., Weintraub, S., Kertesz, A., Mendez, M., Cappa, S. F., Ogar, J. M., Rohrer, J. D., Black, S., Boeve, B. F., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e31821103e6 · Cited by 5,141
Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17
Baker, M., Mackenzie, I. R., Pickering-Brown, S. M., Gass, J., Rademakers, R., Lindholm, C., Snowden, J., Adamson, J., Sadovnick, A. D., Rollinson, S., et al. (2006) · Nature · doi:10.1038/nature05016 · Cited by 2,058 · cited 3×
“nt mode of transmission. Most of them carry heterozygous pathogenic variants in C9orf72, GRN and MAPT genes. Among them, GRN (granulin precursor, OMIM *138945) is responsible for 20% of familial FTD (Baker et al., 2006; Cruts et al., 2006). GRN mutations lead to bvFTD or PPA phenotypes and, less frequently, to a corti…”
BackgroundInfluentialCruts, M., Gijselinck, I., van der Zee, J., Engelborghs, S., Wils, H., Pirici, D., Rademakers, R., Vandenberghe, R., Dermaut, B., Martin, J.-J., et al. (2006) · Nature · doi:10.1038/nature05017 · Cited by 1,512 · cited 4×
“It is well known that heterozygous GRN mutations lead to FTD (Cruts et al., 2006; Baker et al., 2006) but this is the first evidence that homozygous mutations may be evocated in the case of a bvFTD phenotype as well.”
BackgroundInfluentialA harmonized classification system for FTLD-TDP pathology
Mackenzie, I. R. A., Neumann, M., Baborie, A., Sampathu, D. M., Du Plessis, D., Jaros, E., Perry, R. H., Trojanowski, J. Q., Mann, D. M. A., & Lee, V. M. Y. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0845-8 · Cited by 1,017
Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration
Lee, E. B., Lee, V. M.-Y., & Trojanowski, J. Q. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3121 · Cited by 659 · cited 1×
“There is still a debate concerning whether TDP-43 induces neuronal loss by a toxic gain of function of cytoplasmic aggregates or by the loss of its normal function in the nucleus (Lee et al., 2012).”
BackgroundCommon variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions
Van Deerlin, V. M., Sleiman, P. M. A., Martinez-Lage, M., Chen-Plotkin, A., Wang, L.-S., Graff-Radford, N. R., Dickson, D. W., Rademakers, R., Boeve, B. F., Grossman, M., et al. (2010) · Nature Genetics · doi:10.1038/ng.536 · Cited by 579
Sortilin-Mediated Endocytosis Determines Levels of the Frontotemporal Dementia Protein, Progranulin
Hu, F., Padukkavidana, T., Vægter, C. B., Brady, O. A., Zheng, Y., Mackenzie, I. R., Feldman, H. H., Nykjaer, A., & Strittmatter, S. M. (2010) · Neuron · doi:10.1016/j.neuron.2010.09.034 · Cited by 536 · cited 1×
“Progranulin also plays a major role in lysosomes, where it is cleaved into granulins (Hu et al., 2010; Zhou et al., 2017a) and modulates proteins (beta-glucocerebrosidase, cathepsin D) involved in lysosomal disorders (Jian et al., 2016; Zhou et al., 2017b).”
BackgroundStrikingly Different Clinicopathological Phenotypes Determined by Progranulin-Mutation Dosage
Smith, K. R., Damiano, J., Franceschetti, S., Carpenter, S., Canafoglia, L., Morbin, M., Rossi, G., Pareyson, D., Mole, S. E., Staropoli, J. F., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.04.021 · Cited by 489
Van Damme, P., Van Hoecke, A., Lambrechts, D., Vanacker, P., Bogaert, E., van Swieten, J., Carmeliet, P., Van Den Bosch, L., & Robberecht, W. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200712039 · Cited by 418
Cited by
Root, J., Merino, P., Nuckols, A., Johnson, M., & Kukar, T. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105360 · Cited by 238
Frontotemporal lobar degeneration
Grossman, M., Seeley, W. W., Boxer, A. L., Hillis, A. E., Knopman, D. S., Ljubenov, P. A., Miller, B., Piguet, O., Rademakers, R., Whitwell, J. L., et al. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00447-0 · Cited by 178
Microglial efferocytosis: Diving into the Alzheimer’s disease gene pool
Romero-Molina, C., Garretti, F., Andrews, S. J., Marcora, E., & Goate, A. M. (2022) · Neuron · doi:10.1016/j.neuron.2022.10.015 · Cited by 111
Huang, M., Modeste, E., Dammer, E., Merino, P., Taylor, G., Duong, D. M., Deng, Q., Holler, C. J., Gearing, M., Dickson, D., et al. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01037-x · Cited by 103
Neuronal Ceroid Lipofuscinosis: Potential for Targeted Therapy
Specchio, N., Ferretti, A., Trivisano, M., Pietrafusa, N., Pepi, C., Calabrese, C., Livadiotti, S., Simonetti, A., Rossi, P., Curatolo, P., et al. (2020) · Drugs · doi:10.1007/s40265-020-01440-7 · Cited by 78
Zhou, X., Brooks, M., Jiang, P., Koga, S., Zuberi, A. R., Baker, M. C., Parsons, T. M., Castanedes‐Casey, M., Phillips, V., Librero, A. L., et al. (2020) · EMBO reports · doi:10.15252/embr.202050197 · Cited by 61
“Complete loss of PGRN leads to neuronal ceroid lipofuscinosis (NCL), a lysosomal storage disease (Smith et al , 2012; Almeida et al , 2016; Huin et al , 2020).”
del Campo, M., Zetterberg, H., Gandy, S., Onyike, C. U., Oliveira, F., Udeh‐Momoh, C., Lleó, A., Teunissen, C. E., & Pijnenburg, Y. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12643 · Cited by 52
Colella, P., Sayana, R., Suárez-Nieto, M. V., Sarno, J., Nyame, K., Xiong, J., Vera, L. N. P., Basurto, J. A., Corbo, M., Limaye, A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49908-4 · Cited by 59
“Bi-allelic loss of function (lof) mutations cause Neuronal Ceroid Lipofuscinosis type 11 (CLN11, OMIM 614706), a rare LSD characterized by childhood-onset cognitive decline, retinitis pigmentosa, and early death 38 .”
Tweaking Progranulin Expression: Therapeutic Avenues and Opportunities
Terryn, J., Verfaillie, C. M., & Damme, P. V. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.713031 · Cited by 48
“While only a few patients have been described with homozygous loss of GRN (Huin et al., 2020), the genetic and pathological link to NCL confirmed a previously suspected role for GRN in the lysosome.”
BackgroundNeurodevelopmental Clues to Neurodegeneration
Schor, N. F., & Bianchi, D. W. (2021) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2021.07.012 · Cited by 52
Neuronal VCP loss of function recapitulates FTLD-TDP pathology
Wani, A., Zhu, J., Ulrich, J. D., Eteleeb, A. M., Sauerbeck, A. D., Reitz, S. J., Arhzaouy, K., Ikenaga, C., Yuede, C. M., Pittman, S. K., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109399 · Cited by 46
“This spectrum of pathology may correlate with GRN protein levels, and augmenting GRN levels may be therapeutic (Huin et al., 2020).”
BackgroundInfluentialRoot, J., Mendsaikhan, A., Taylor, G., Merino, P., Nandy, S., Wang, M., Araujo, L. T., Ryu, D., Holler, C., Thompson, B. M., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114985 · Cited by 39
Syndromic retinitis pigmentosa.
Karuntu, J. S., Almushattat, H., Nguyen, X.-T.-A., Plomp, A. S., Wanders, R. J. A., Hoyng, C. B., van Schooneveld, M. J., Schalij-Delfos, N. E., Brands, M. M., Leroy, B. P., et al. (2025) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2024.101324 · Cited by 39
TDP-43 Proteinopathy and Tauopathy: Do They Have Pathomechanistic Links?
Riku, Y., Yoshida, M., Iwasaki, Y., Sobue, G., Katsuno, M., & Ishigaki, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415755 · Cited by 38
Delivering progranulin to neuronal lysosomes protects against excitotoxicity
Davis, S. E., Roth, J. R., Aljabi, Q., Hakim, A. R., Savell, K. E., Day, J. J., & Arrant, A. E. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100993 · Cited by 28
Mol, M. O., Miedema, S. S. M., Swieten, J. C. V., van Rooij, J., & Dopper, E. G. P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910298 · Cited by 25
Neuronal Ceroid Lipofuscinosis—Concepts, Classification, and Avenues for Therapy
Zhang, Y., Du, B., Zou, M., Peng, B., & Rao, Y. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70261 · Cited by 36
Frew, J., & Nygaard, H. B. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01158-x · Cited by 25
Preclinical Interventions in Mouse Models of Frontotemporal Dementia Due to Progranulin Mutations
Kashyap, S. N., Boyle, N. R., & Roberson, E. D. (2023) · Neurotherapeutics · doi:10.1007/s13311-023-01348-6 · Cited by 22
“The retina is another 1 3 prominent site of pathology for NCLs, and visual impairment is a common early sign for many cases of NCL [57].”
BackgroundInfluentialProgranulin deficiency in the brain: the interplay between neuronal and non-neuronal cells
Gawęda-Walerych, K., Aragona, V., Lodato, S., Sitek, E. J., Narożańska, E., & Buratti, E. (2025) · Translational Neurodegeneration · doi:10.1186/s40035-025-00475-8 · Cited by 23
“These patients presented a less severe neurological phenotype consistent with bvFTD ± parkinsonism occurring after the age of 50 [37].”
InfluentialZhou, X., Kukar, T. L., & Rademakers, R. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-51140-1_14 · Cited by 25
Sellami, L., Saracino, D., & Ber, I. L. (2020) · Revue Neurologique · doi:10.1016/j.neurol.2020.02.008 · Cited by 23
Self-citationPhenotypic Variability of Retinal Disease Among a Cohort of Patients With Variants in the CLN Genes
Kolesnikova, M., de Carvalho, J. R. L., Oh, J. K., Soucy, M. E., Demirkol, A., Kim, A. H., Tsang, S. H., & Breazzano, M. P. (2023) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.64.3.23 · Cited by 21
Lysosomal Diseases and Neuropsychiatry: Opportunities to Rebalance the Mind
Cox, T. M. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00177 · Cited by 17
The complex relationship between genotype, pathology and phenotype in familial dementia
Kwok, J. B., Loy, C. T., Dobson‐Stone, C., & Halliday, G. M. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105082 · Cited by 18
Munn, C. G., Burton, S., Dickerson, S., Bakshy, K., Strouse, A., & Rajesh, D. (2021) · PLoS ONE · doi:10.1371/journal.pone.0250107 · Cited by 21
“Heterozygous GRN mutations cause frontotemporal dementia (FTD) with transactive response DNA-binding protein of 43 kD (TDP43)–positive inclusions [16].”
BackgroundBernardi, S., Gemignani, F., & Marchese, M. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106258 · Cited by 17
“Patients with progranulin deficiency showed vision loss, seizures, and cognitive and language deterioration (Smith et al., 2012; Huin et al., 2020).”
Elevated levels of extracellular vesicles in progranulin‐deficient mice and FTD‐GRN Patients
Arrant, A. E., Davis, S. E., Vollmer, R. M., Murchison, C., Mobley, J. A., Nana, A. L., Spina, S., Grinberg, L. T., Karydas, A. M., Miller, B. L., et al. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51242 · Cited by 17
Davis, S. E., Cook, A. K., Hall, J. A., Voskobiynyk, Y., Carullo, N. V. N., Boyle, N. R., Hakim, A. R., Anderson, K. M., Hobdy, K. P., Pugh, D. A., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01571-4 · Cited by 12
The role of endolysosomal progranulin and TMEM106B in neurodegenerative diseases
Takahashi, H., & Strittmatter, S. M. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00873-6 · Cited by 16
“…some presenting classical CLN11 symptoms at early age of onset and others showing a distinct delayed phenotype of fronto-temporal dementia after 40 or 50 years, suggesting that CLN11 and FTLD-TDP are extreme phenotypes of a common spectrum of disorders caused by biallelic GRN mutations [28] (Fig.”
Petkau, T. L., Life, B. E., Lu, G., Yang, J., Fornés, O., Wasserman, W. W., Simpson, E. M., & Leavitt, B. R. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105314 · Cited by 14
Deng, B., Zheng, Z., Zheng, J., Yang, W., Huang, Y., Luo, Y., Jin, D., Shen, L. H., Jin, K., & Wang, Q. (2021) · Aging and Disease · doi:10.14336/ad.2021.0309 · Cited by 13
Khrouf, W., Saracino, D., Rucheton, B., Houot, M., Clot, F., Rinaldi, D., Vítor, J., Huynh, M., Heng, E., Schlemmer, D., et al. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106108 · Cited by 12
Self-citationCabron, A.-S., Borgmeyer, U., Richter, J., Peisker, H., Gutbrod, K., Dörmann, P., Capell, A., & Daμμe, M. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01510-3 · Cited by 15
Biological basis and psychiatric symptoms in frontotemporal dementia
Mori, K., & Ikeda, M. (2022) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13375 · Cited by 13
Root, J. T., Mendsaikhan, A., Nandy, S., Taylor, G., Wang, M., Araujo, L. T., Merino, P., Ryu, D., Holler, C. J., Thompson, B. M., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.17.536004 · Cited by 11
“Complete deficiency of PGRN causes neuronal ceroid lipofuscinosis (NCL), a neurodegenerative lysosomal storage disorder (LSD).(5,6) Moreover, genetic variants in GRN decrease PGRN levels and have been”
BackgroundsPLA2-IIA modifies progranulin deficiency phenotypes in mouse models
Yang, C., Du, H., Lee, G. B., Uematsu, M., He, W., Doré, É., Yu, W., Sanford, E. J., Smolka, M. B., Boilard, É., et al. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00863-8 · Cited by 11
“Complete loss of PGRN in humans causes neuronal ceroid lipofuscinosis (NCL) [6–8], a group of lysosomal storage diseases (LSDs).”
Early-onset phenotype of bi-allelic GRN mutations
Neuray, C., Sultan, T., Alvi, J. R., França, M. C., Assmann, B. E., Wagner, M., Canafoglia, L., Franceschetti, S., Rossi, G., Santana, I. J., et al. (2020) · Brain · doi:10.1093/brain/awaa414 · Cited by 12
Two heterozygous progranulin mutations in progressive supranuclear palsy
Yang, W., Deng, B., Huang, Y., Liu, J., Huang, Z., Chang, Z., Zhu, S., Chan, L. L., Chaudhuri, К. R., Tan, E., et al. (2020) · Brain · doi:10.1093/brain/awaa428 · Cited by 9
Research trend on dyscalculia by bibliometric analysis during 2017-2022
Deda, Y. N., Disnawati, H., Ekawati, R., & Suprapto, N. (2023) · International Journal of Evaluation and Research in Education (IJERE) · doi:10.11591/ijere.v13i1.25992 · Cited by 12
“Based on [25] Trends in Neuroscience and Education 51 [26] Journal of Learning Disabilities 39 [27] Child Development 33 [28] Brain 28 [29] Journal of Child Psychology and Psychiatry and Allied Disciplines”
BackgroundCharacterization of Progranulin Gene Mutations in Portuguese Patients with Frontotemporal Dementia
Almeida, M. R., Tábuas‐Pereira, M., Baldeiras, I., Lima, M., Durães, J., Massano, J., Pinto, M. M. M., Cruto, C., & Santana, I. J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010511 · Cited by 10
“At age 25, she presented visual hallucinations and the cerebellar ataxia worsened, with saccadic pursuit, nystagmus, severe dysarthria, and dysphagia [34].”
BackgroundBossolasco, P., Cimini, S., Maderna, E., Bardelli, D., Canafoglia, L., Cavallaro, T., Ricci, M., Silani, V., Marucci, G., & Rossi, G. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105891 · Cited by 8
“[11] showed the presence of fingerprint storage material, as expected.”
BackgroundResultInfluentialSmith, D. M., Aggarwal, G., Niehoff, M. L., Jones, S. A., Banerjee, S., Farr, S. A., & Nguyen, A. D. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04190-9 · Cited by 13
“In contrast to heterozygous GRN mutations, complete progranulin deficiency causes neuronal ceroid lipofuscinosis (NCL), CLN11, with disease onset usually in the teenage to midlife years, although this can vary widely [20–22].”
PGRN as an emerging regulator of lipid metabolism in neurodegenerative diseases
Shi, Y., Hou, W., Li, B., & Zhu, C. (2025) · Communications Biology · doi:10.1038/s42003-025-08272-9 · Cited by 10
TFEB overexpression alleviates autophagy-lysosomal deficits caused by progranulin insufficiency
Nader, W. O., Brown, K. S., Boyle, N. R., Kaplelach, A. K., Abdelaziz, S. M., Davis, S. E., Aljabi, Q., Hakim, A. R., Davidson, A. G., Vollmer, G. A., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-12268-0 · Cited by 10
Preclinical and Prodromal Frontotemporal Dementia: Challenges and Opportunities
Palacino, F., Manganotti, P., & Benussi, A. (2025) · International Journal of Translational Medicine · doi:10.3390/ijtm5040052 · Cited by 7
Regulation of extracellular progranulin in medial prefrontal cortex
Kaplelach, A. K., Fox, S. N., Cook, A. K., Hall, J. A., Dannemiller, R., Jaunarajs, K. L. E., & Arrant, A. E. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106326 · Cited by 7
Kara, İ. S., Köse, E., Çavdarlı, B., & Eminoğlu, F. T. (2024) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2023-0411 · Cited by 7
Haukedal, H., Lorenzen, S. S., Westi, E. W., Corsi, G. I., Gadekar, V. P., McQuade, A., Davtyan, H., Doncheva, N. T., Schmid, B., Chandrasekaran, A., et al. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.07.024 · Cited by 8
“Recent studies have further confirmed that such genetic variants can cause different phenotypic outcome dependent on their mono- or biallelic state (Huin et al., 2020), supporting our findings of an alternate heterozygous and homozygous FTD3 microglia phenotype.”
ResultFurther description of the phenotypic spectrum of neuronal ceroid lipofuscinosis type 11
Nóbrega, P. R., de Paiva, A. R. B., Amorim, A., Lima, P. L. G. D. S. B., Cabral, K. S. S., de Barcelos, I. P., Pessoa, A. L. S., Lima, C. F. S., Castro, M. A. A., Freua, F., et al. (2024) · Genetics in Medicine · doi:10.1016/j.gim.2024.101291 · Cited by 8
Ocular Manifestations of Neuronal Ceroid Lipofuscinoses
Singh, R. B., Gupta, P., Kartik, A., Farooqui, N., Singhal, S., Shergill, S., Singh, K. P., & Agarwal, A. K. (2021) · Seminars in Ophthalmology · doi:10.1080/08820538.2021.1936571 · Cited by 7
“The patients present with cerebellar ataxia, seizures, retinitis pigmentosa, and later, frontal cognitive disorders, between 13 and 25 years of age.(140) Neuroimaging of the patients shows cerebellar atrophy, and EEG reveals poly spikewave discharges with posterior emphasis.”
BackgroundA variant in GRN of Spanish origin presenting with heterogeneous phenotypes
Menéndez‐González, M., García-Martínez, A., Fernández‐Vega, I., Pitiot, A., & Álvarez, V. (2022) · Neurología (English Edition) · doi:10.1016/j.nrleng.2022.10.001 · Cited by 5
Cimini, S., Bellini, S., Saraceno, C., Benussi, L., Ghidoni, R., Giliani, S., Puoti, G., Canafoglia, L., Giaccone, G., & Rossi, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213753 · Cited by 5
“In a recent post-mortem analysis of a human brain carrying a homozygous GRN mutation, only a very mild TDP-43 pathology was described, without any positive detection of aggregated forms, while lysosomal storage disorder was overwhelming [14].”
BackgroundOutcomes of progranulin gene therapy in the retina are dependent on time and route of delivery
Zin, E. A., Han, D., Tran, J., Morrison‐Welch, N., Visel, M., Kuronen, M., & Flannery, J. G. (2021) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2021.05.009 · Cited by 6
“These patients present vision loss, seizures, ataxia, and cognitive decline.(5) Interestingly, singleallele mutations in GRN may also cause frontotemporal dementia (FTD).”
BackgroundMetabolic Disorders With Associated Movement Abnormalities
Singer, H. S., Mink, J. W., Gilbert, D. L., & Jankovic, J. J. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-820552-5.00018-8 · Cited by 6
Kennedy, J. C., Vargas, S. O., Fishman, M. P., Alesi, N., Baek, S.-H., Khabibillin, D., Platt, C. D., Garcia-de-Alba, C., Agrawal, P. B., Carmichael, N. E., et al. (2025) · Med · doi:10.1016/j.medj.2025.100607 · Cited by 6
Genetic modifiers of epilepsy: A narrative review
Rizvi, S., Raza, S. T., & Mahdi, F. (2025) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2025.104038 · Cited by 4
Retinal Degeneration and Microglial Dynamics in Mature Progranulin-Deficient Mice
Takahashi, K., Nakamura, S., Shimazawa, M., & Hara, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111557 · Cited by 5
“In addition, both heterozygous and homozygous mutations in the GRN gene are associated with autofluorescent aggregates in the retina and brain [6,7].”
BackgroundCook, A. K., Greathouse, K. M., Manuel, P. N., Cooper, N. H., Eberhardt, J. M., Freeman, C. D., Weber, A. J., Herskowitz, J. H., & Arrant, A. E. (2024) · Molecular Brain · doi:10.1186/s13041-024-01095-5 · Cited by 5
“People with loss-of-function mutations on both GRN alleles, resulting in complete pro-granulin deficiency, develop the lysosomal storage disorder Neuronal Ceroid Lipofuscinosis (NCL) [6, 7].”
BackgroundAlves, G. M., Caravelas, R. A. M., Gonçalves, T. A. P., Corniani, K. F., Nather, J. C., Geraldi-Tomaselli, C. V., Frezatti, R. S. S., Fernandes, R. M. F., dos Santos, A. C., Marques, W., et al. (2025) · Neurogenetics · doi:10.1007/s10048-025-00800-3 · Cited by 4
Budda, B., Mitra, A., Park, L., Long, H., Kurnellas, M., Bien‐Ly, N., Estacio, W. F., Burgess, B., Chao, G., Schwabe, T., et al. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01817-4 · Cited by 8
Atiskova, Y., Kohlschütter, A., Spitzer, M. S., & Dulz, S. (2020) · Der Ophthalmologe · doi:10.1007/s00347-020-01282-4 · Cited by 5
Progranulin Insufficiency Affects Lysosomal Homeostasis in Retinal Pigment Epithelium
Takahashi, K., Nakamura, S., Shimazawa, M., & Hara, H. (2022) · In Vivo · doi:10.21873/invivo.12744 · Cited by 4
Younes, T. B., Kraoua, I., Snanoudj, S., Klaa, H., Benrhouma, H., Rouissi, A., Caillaud, C., Châabouni, M., Miladi, N., Bekri, S., et al. (2022) · Clinical Genetics · doi:10.1111/cge.14145 · Cited by 2
Self-citationGuardia, A., Fernández, A., Seruggia, D., Chotard, V., Sánchez‐Castillo, C., Kutsyr, O., Sánchez‐Sáez, X., Zurita, E., Cantero, M., Rebsam, A., et al. (2023) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.64.13.32 · Cited by 3
Rossi, G., Salvi, E., Benussi, L., Mehmeti, E., Geviti, A., Bellini, S., Longobardi, A., Facconi, A., Carrara, M., Bonvicini, C., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112847 · Cited by 2
“Rare homozygous GRN mutations mostly cause neuronal ceroid lipofuscinosis (NCL), a lysosomal storage disorder that shares some neuropathological features with FTLD caused by heterozygous GRN mutations [22,23].”
BackgroundReply: Two heterozygous progranulin mutations in progressive supranuclear palsy
Huin, V., Barbier, M., Dürr, A., & Ber, I. L. (2021) · Brain · doi:10.1093/brain/awaa456 · Cited by 2
Self-citationNeuronal ceroid lipofuscinosis type 11 in early childhood
Singh, C., Kiran, N., Kampani, G., & Dhamija, K. (2025) · BMJ Case Reports · doi:10.1136/bcr-2025-265803 · Cited by 1
The role of Grn in the development of mouse cochlear nucleus synapses
Deng, M., & Hu, Z. (2026) · Hearing Research · doi:10.1016/j.heares.2026.109674 · Cited by 1
Lysosomal dysfunction in neurodegenerative disease
Brooker, S. M., Coukos, R., & Krainc, D. (2026) · Nature Reviews Neurology · doi:10.1038/s41582-026-01262-3 · Cited by 2
“Homozygous loss-of-function GRN variants cause the LSD neuronal ceroid lipofuscinosis, consistent with a crucial role for progranulin in regulating lysosomal integrity 24,240,241 .”
A variant in GRN of Spanish origin presenting with heterogeneous phenotypes
Menéndez‐González, M., García-Martínez, A., Fernández‐Vega, I., Pitiot, A., & Álvarez, V. (2025) · Neurología · doi:10.1016/j.nrl.2022.09.004 · Cited by 1
Progranulin loss induces mitochondrial dysfunction and ferroptosis in human cerebral organoidsPreprint
Camargo, C. M., Almeida, M. C., Mejía‐Cupajita, B., Hwang, I., Faynus, M. A., Carrettiero, D. C., & Kosik, K. S. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.11.29.691344 · Cited by 1
Reply: Early-onset phenotype of bi-allelicGRNmutations
Huin, V., Barbier, M., Dürr, A., & Ber, I. L. (2020) · Brain · doi:10.1093/brain/awaa415
Self-citationFrew, J. (2021) · cIRcle (University of British Columbia) · doi:10.14288/1.0396548
Lee, C. (2021) · cIRcle (University of British Columbia) · doi:10.14288/1.0400595
“However, whether lysosomal dysfunction leads directly to FTLD is unclear, and is best exemplified by an individual who possessed a homozygous GRN mutation and developed CLN11, but showed none of the behavioral dysfunction found in FTLD-GRN (48).”
BackgroundCorrecting the Aberrant Progranulin-Deficient Lysosomal Proteome via HDAC InhibitionPreprint
Werthmann, G. C., Tesla, R., Wong, C. H. Y., Haggarty, S. J., & Herz, J. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4160142
Degenerazioni lobari frontotemporali: neuropatologia, genetica e classificazione
Saracino, D., Ber, I. L., & Deramecourt, V. (2024) · EMC - Neurologia · doi:10.1016/s1634-7072(24)49339-2
Self-citationShi, D., Bao, J., Wu, H., Huang, B., Zheng, Y., Xu, F., Wang, H., Liu, J. J., Guan, S., & Du, K. (2025) · Neurological Sciences · doi:10.1007/s10072-025-08472-5
“Notably, Huin et al. have demonstrated that serum progran-ulin is detectable in healthy individuals, and a preliminary threshold for the normal concentration has been established at 472 mg/L [6 ].”
InfluentialAblation of progranulin augments microglial activation and accelerates prion progression
Li, B., Shi, Y., Hou, W., Guan, H., Li, J., Yi, T., Li, W., Cai, D., Schwarz, P., Aguzzi, A., et al. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-02128-3
Delivering Progranulin to Astrocytic Lysosomes Promotes Growth of Co‐Cultured Neurons
Kaplelach, A. K., Hall, J. A., Nader, W. O., Davidson, A. G., Ireland, M. D., Ianov, L., & Arrant, A. E. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70284 · Cited by 1
“Progranulin localizes to lysosomes and is necessary for maintaining lysosomal function, as people with mutations on both GRN alleles develop a lysosomal storage disorder, neuronal ceroid lipofuscinosis (Huin et al. 2019; Smith et al. 2012).”
Disrupted Cellular Clearance and Inflammatory Loops in Frontotemporal Dementia
Halagali, P., Tippavajhala, V. K., Sharma, H., Abalkhail, A., & Almagharbeh, W. T. (2025) · Springer eBooks · doi:10.1007/978-981-95-3945-1_13
Huang, M., Modeste, E. S., Dammer, E., Merino, P., Taylor, G., Duong, D. M., Deng, Q., Holler, C. J., Gearing, M., Dickson, D. W., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13064301
Huang, M., Modeste, E. S., Dammer, E., Merino, P., Taylor, G., Duong, D. M., Deng, Q., Holler, C. J., Gearing, M., Dickson, D. W., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13064298
Cabron, A.-S., Borgmeyer, U., Richter, J., Peisker, H., Gutbrod, K., Dörmann, P., Capell, A., & Daμμe, M. (2024) · Figshare · doi:10.6084/m9.figshare.26564529
Cabron, A.-S., Borgmeyer, U., Richter, J., Peisker, H., Gutbrod, K., Dörmann, P., Capell, A., & Daμμe, M. (2024) · Figshare · doi:10.6084/m9.figshare.26564526
Frew, J., & Nygaard, H. B. (2021) · Figshare · doi:10.6084/m9.figshare.14361506
Étude de la composante neuroinflammatoire dans les DFT/SLA
Smeyers, J. (2020) · theses.fr (ABES) · doi:10.70675/219cfa6fz5b3az4198z9deczdfaad3cd784c
Differential lysosomal burden in the excitatory and inhibitory neurons of the FTD-GRN brain.
Joyce, J. (2023) · theses.fr (ABES) · doi:10.70675/48f8ae85z4049z4ff7za748z0b87206a8dab
Progranulin Is a Survival Factor for Axotomized Retinal Ganglion Cells in Adult Mice
Grodzki, L. M., Schlichting, S., Hu, Y., Helbing, S., & Bartsch, U. (2026) · Cells · doi:10.3390/cells15110988
“In the retina, PGRN deficiency not only causes loss of RGCs but also of photoreceptor cells [39,68,71,73,79].”
Rényi eigen-entropy: A data-based method for perturbation discrimination in gene regulatory networks
Lu, X., Xue, Z., & Wang, R. (2026) · Physica A Statistical Mechanics and its Applications · doi:10.1016/j.physa.2026.131787
From biology to therapy: advances in progranulin-related neurodegenerative diseases
Hu, S., Qiu, K., Zhen, F., & Zhou, X. (2026) · Molecular Neurodegeneration Advances · doi:10.1186/s44477-026-00042-z
“The clinical phenotype of CLN11 is typically characterized by progressive retinal degeneration, refractory epilepsy, rapidly declining cognitive function, and cerebellar ataxia, with onset spanning adolescence to early adulthood [119–121 , 124].”
Mutlu, M. B., Sezer, A., Özdemir, E., Bayram, A. K., GÜVEN, D. C., Yılmaz, Ş., Sazlı, N., Karataş, D., Öz, E., Bayramlar, Z., et al. (2026) · Journal of Human Genetics · doi:10.1038/s10038-026-01503-9
So, I., Birkle, T. J. Y., Duff, K., Restrepo-Martínez, M., Ducharme, S., & Finger, E. C. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71754 · Cited by 1
Sattaporn, C., Lusawat, A., Sudachan, P., Rojanawatsirivej, A., Vatanavicharn, N., Liammongkolkul, S., lttiwut, R., lttiwut, C., Od‐Ek, P., Srichomthong, C., et al. (2026) · Brain and Development · doi:10.1016/j.braindev.2026.104593
Autophagy-lysosomal pathway in neurodegeneration
McDonough, S. R., Rao, A. K., McAleer, J. M., Babrowicz, B. M., & Sharma, M. (2026) · Molecular Neurodegeneration Advances · doi:10.1186/s44477-026-00041-0
Gene therapy in neuronal ceroid lipofuscinosis (NCL)
Namini, M. S., Mousavi, S. A. R., & Kazemi, A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40467-2.00002-6
Metadata
- Authors
- Huin, V., Barbier, M., Bottani, A., Lobrinus, J. A., Clot, F., Lamari, F., Chat, L., Rucheton, B., Fluchère, F., Auvin, S., Myers, P., Gelot, A., Camuzat, A., Caillaud, C., Jornéa, L., Forlani, S., Saracino, D., Duyckaerts, C., Brice, A., Durr, A., & Le Ber, I.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- University Hospital of Geneva (CH)
- Assistance Publique – Hôpitaux de Paris (FR)
- Aix-Marseille Université (FR)
- Medical Office, Geneva, Switzerland
- Neuropathology, Department of Pathology, Trusseau Hospital, AP-HP, Paris, France and INMED INSERM U901 Luminy Campus, Aix-Marseille University, France
- Hôpital Necker-Enfants Malades (FR)
- Sorbonne Université, Institut du Cerveau et de la Moelle épinière (ICM), AP-HP, INSERM, CNRS, University Hospital Pitié-Salpêtrière, Paris, France
- ORCID
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-12-19
- Volume
- 143
- Issue
- 1
- Pages
- 303-319
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2996162164
- Cited by
- 96
- References
- 53
- Citations by year
- 2026: 10 · 2025: 18 · 2024: 9 · 2023: 14 · 2022: 12 · 2021: 17 · 2020: 16
- FWCI
- 7.71
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Brain (publishedVersion)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (publishedVersion)
- arXiv (Cornell University) (submittedVersion)
- HAL (submittedVersion, other-oa)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- arXiv (Cornell University)
- Funders
- VERUM (ANR-11-INBS-0011 – NeurATRIS)
- Translational Research Infrastructure for Biotherapies in Neurosciences
- Programme Hospitalier de Recherche Clinique
- PHRC
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
- Keywords
- GRN mutations, progranulin, frontotemporal dementia, TDP-43, lysosomal storage disease, phenotypic variability, age of onset, splice site mutation, neuropathology, semidominant inheritance, genetic counseling, molecular diagnosis
- MeSH terms
- Progranulins, Adolescent, Adult, Cerebellar Ataxia, Child, Epilepsy, Female, Heterozygote, Homozygote, Humans, Male, Middle Aged, Mutation, Neuronal Ceroid-Lipofuscinoses, Retinitis Pigmentosa, RNA Splicing, Age of Onset, Parkinsonian Disorders, Rare Diseases, Young Adult, TDP-43 Proteinopathies, Frontotemporal Dementia, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.